Onivyde (irinotecan liposome injection) for the Treatment of ... | 合法藥品大搜索

Onivyde is an intravenous injection approved for the treatment of metastatic pancreatic cancer. Image: courtesy of Merrimack Pharmaceuticals. Onivyde contains a topoisomerase inhibitor called irinotecan liposome. Image: courtesy of Merrimack Pharmaceuticals. Pancreatic cancer originates in the pancreas and spreads to other parts of the body in the late stage. Image: courtesy of JasonRobertYoungMD.

Onivyde (MM-398 / irinotecan liposome injection) is an intravenous injection indicated for the treatment of metastatic pancreatic cancer.

The drug was developed by Merrimack Pharmaceuticals in collaboration with Baxalta, a subsidiary of Baxter.

The drug’s development[1], manufacturing and commercialisation right...

Onivyde (irinotecan liposome injection) for the Treatment of ... | 合法藥品大搜索

Metastatic Pancreatic Cancer Treatment Option | 合法藥品大搜索

ONIVYDE (irinotecan liposome injection) is proven to help people with metastatic pancreatic cancer, who previously received gemcitabine chemotherapy, live ... Read More

Liposomal Irinotecan | 合法藥品大搜索

由 JE Frampton 著作 · 2020 · 被引用 4 次 — Key words were liposomal irinotecan, Onivyde, pancreatic cancer. Records were limited to those in ... Read More

FDA grants fast track designation to Onivyde for advanced ... | 合法藥品大搜索

2020年6月17日 — “Since the initial approval of Onivyde in metastatic pancreatic cancer, we have continued to dedicate our research efforts to better understand ... Read More

Pancreatic Cancer Study Program – National Institute of ... | 合法藥品大搜索

ONIVYDETM. One of the most exciting achievement of NICR in the past years is the success of a global, randomized phase III NAPOLI- ... Read More

NAPOLI | 合法藥品大搜索

由 A Wang-Gillam 著作 · 2019 · 被引用 65 次 — Longer overall survival in metastatic pancreatic cancer post–first line ... Liposomal irinotecan (nal-IRI; Onivyde®; Ipsen Biopharmaceuticals, Inc. Read More

Onivyde (Irinotecan Liposome Injection) a New Treatment ... | 合法藥品大搜索

由 LA Raedler 著作 · 被引用 1 次 — The FDA approval of irinotecan liposome injection has added a new treatment option for patients with pancreatic cancer. The drug is only approved for use in ... Read More

Ipsen receives FDA Fast Track designation for liposomal ... | 合法藥品大搜索

2020年6月17日 — “Since the initial approval of ONIVYDE® in metastatic pancreatic cancer, we have continued to dedicate our research efforts to better ... Read More

The safety and efficacy of Onivyde (irinotecan liposome ... | 合法藥品大搜索

由 FC Passero Jr 著作 · 2016 · 被引用 61 次 — Introduction: Patients with advanced and metastatic pancreatic cancer refractory to gemcitabine based therapy have a dismal prognosis and limited therapeutic ... Read More

Liposomal Irinotecan Regimen Pushes Toward Frontline ... | 合法藥品大搜索

2020年8月18日 — ... the NAPOLI-1 and NAPOLI-3 trials in metastatic pancreatic cancer, ... In October 2015, the FDA approved liposomal irinotecan (Onivyde) in ... Read More

相關資訊整理